EPS for Meridian Bioscience (VIVO)

EPS in 2022 (TTM): HK$7.59

According to Meridian Bioscience's latest financial reports the company's current EPS (TTM) is HK$7.60. In 2021 the company made an earnings per share (EPS) of HK$10.81 a decrease over its 2020 EPS that were of HK$12.76.

EPS history for Meridian Bioscience from 2012 to 2022

Annual EPS

Year	EPS	Change
2022 (TTM)	HK$7.59	-29.8%
2021	HK$10.81	-15.34%
2020	HK$12.76	254.35%
2019	HK$3.60	-23.33%
2018	HK$4.70	15.38%
2017	HK$4.07	-26.76%
2016	HK$5.56	-18.39%
2015	HK$6.81	2.35%
2014	HK$6.66	-5.56%
2013	HK$7.05	4.65%
2012	HK$6.73

EPS for similar companies or competitors

Company	EPS	EPS differencediff.	Country
Thermo Fisher Scientific TMO	HK$139.15	1,731.96%	🇺🇸 USA
Becton Dickinson BDX	HK$42.76	462.89%	🇺🇸 USA
Hologic HOLX	HK$19.03	150.52%	🇺🇸 USA
QuidelOrtho QDEL	-HK$130.46	-1,817.53%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions